BioPharmaTrend
Latest News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers

  Latest News

HP and Tecan Launch Combined Single-Cell and Reagent Dispenser, Report 40x Faster Dosing for Drug Discovery

by BiopharmaTrend   •   May 26, 2025  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

HP and Tecan have launched the Duo Digital Dispenser, a system that combines single-cell isolation and reagent dispensing in one unit. According to the companies, the system leverages HP’s inkjet microfluidics and Tecan’s automation platform to reduce dosing times from 10 minutes to 15 seconds—reportedly 40 times faster than conventional methods. The instrument can also isolate single cells in under five minutes, compared to up to an hour using standard protocols.

#advertisement
AI in Drug Discovery Report 2025

The device features a single-use disposable component designed to reduce contamination and improve reproducibility. It also enables surfactant-free reagent dispensing, which is highlighted as particularly relevant for biologics workflows.

The Duo Digital Dispenser

Duo builds on the integration of HP’s D300e Digital Dispenser and Uno Single Cell Dispenser technologies. The companies stated that the new platform is intended to improve accessibility of next-generation microfluidics for labs lacking in-house specialization.

HP and Tecan plan to continue co-developing microfluidics and sensing technologies to further expand the capabilities of Duo.

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.